• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 11500A
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Tissue Breakdown (2681)
Event Date 08/31/2023
Event Type  Injury  
Event Description
Through implant patient registry and investigation, it was learned a 25mm 11500a aortic valve was explanted at implant due to disruption of the right coronary sinus (after decannulation).The explanted device was replaced with another 25mm 11500a aortic valve with pericardial patch repair of the aortic root.Per medical records, the patient presented with severe nonrheumatic native aortic valve stenosis and underwent a avr.Intraoperatively the heavily calcified native valve was removed, annulus decalcified and sized.A 25mm 11500a was inserted in the supra-annular position with 16 interrupted pledget mattress sutures and secured with cor-knots.The valve was seated well below the coronary ostia.Tee demonstrated normal functioning valve.After weaning from bypass and administration of protamine, bleeding started to emanate from the anterior surface of the aortic root.The patient was recannulated.A stellate disruption of the rc sinus just above the valve adjacent to the left right commissure was identified.The valve was removed, bovine pericardial patch was used to correct the defect.Another 25mm 11500a was implanted and was seated well below the coronary ostia.Post tee demonstrated normally functioning aortic valve and normal biventricular function.The patient was transferred to the icu in critical condition.On pod #4, the patient was discharged home with aspirin 81mg qd in stable condition.Edwards lifesciences maintains an implant patient registry.This registry is a patient tracking mechanism for serialized edwards implantable devices (bioprosthetic heart valves and annuloplasty rings), rather than a true post-market surveillance registry.Through the registry, edwards is notified when these devices are implanted.In addition, patient and/or device status may be reported to the registry via the implantation data cards.The information is received from various sources (e.G.Surgeon, hospital, and patient family members) and is not received in the form of a conventional customer complaint.The information reported may or may not be related to the edwards device.
 
Manufacturer Narrative
The device was not returned to edwards for evaluation as it is not available.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Manufacturer Narrative
The device history record was reviewed and shows that this device met all manufacturing specifications for product release prior to distribution.No issues were identified that would have impacted this event.The most likely cause is procedural factors.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS INSPIRIS RESILIA AORTIC VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer Contact
saurav singh
1 edwards way
irvine, CA 92614
9492506615
MDR Report Key18141632
MDR Text Key328185837
Report Number2015691-2023-17510
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00690103194999
UDI-Public(01)00690103194999(17)270620
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/30/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/15/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number11500A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received11/21/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/21/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization; Life Threatening;
Patient Age68 YR
Patient SexMale
-
-